Catalysts for Zydus Therapeutics Inc
52 tracked
Sep 17, 2024
approval
BOSENTAN — FDA approval
Zydus Therapeutics Inc
→
May 30, 2024
approval
BOSENTAN — FDA approval
Zydus Therapeutics Inc
→
Dec 15, 2023
approval
FENTANYL-100 (FENTANYL) — FDA approval
Zydus Therapeutics Inc
→
Dec 15, 2023
approval
FENTANYL-100 (FENTANYL) — FDA approval
Zydus Therapeutics Inc
→
Aug 29, 2023
approval
ISOTRETINOIN — FDA approval
Zydus Therapeutics Inc
→
Mar 30, 2023
approval
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approval
Zydus Therapeutics Inc
→
Mar 27, 2023
approval
HALOPERIDOL DECANOATE — FDA approval
Zydus Therapeutics Inc
→
Mar 9, 2023
approval
OLANZAPINE — FDA approval
Zydus Therapeutics Inc
→
Jan 24, 2023
approval
FENTANYL-100 (FENTANYL) — FDA approval
Zydus Therapeutics Inc
→
Jun 17, 2022
approval
TRANEXAMIC ACID — FDA approval
Zydus Therapeutics Inc
→
May 25, 2022
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Zydus Therapeutics Inc
→
Apr 29, 2022
approval
BOSENTAN — FDA approval
Zydus Therapeutics Inc
→
Mar 10, 2021
approval
LAMOTRIGINE — FDA approval
Zydus Therapeutics Inc
→
Apr 1, 2020
approval
LAMOTRIGINE — FDA approval
Zydus Therapeutics Inc
→
Nov 1, 2019
approval
BOSENTAN — FDA approval
Zydus Therapeutics Inc
→
Oct 22, 2019
approval
HALOPERIDOL DECANOATE — FDA approval
Zydus Therapeutics Inc
→
Apr 26, 2019
approval
BOSENTAN — FDA approval
Zydus Therapeutics Inc
→
May 14, 2018
approval
TRANEXAMIC ACID — FDA approval
Zydus Therapeutics Inc
→
Sep 28, 2017
approval
DOXYCYCLINE — FDA approval
Zydus Therapeutics Inc
→
Aug 8, 2017
approval
DILTIAZEM HYDROCHLORIDE — FDA approval
Zydus Therapeutics Inc
→
Jul 17, 2017
approval
TRANEXAMIC ACID — FDA approval
Zydus Therapeutics Inc
→
Mar 3, 2017
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
Zydus Therapeutics Inc
→